SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-007184
Filing Date
2023-01-12
Accepted
2023-01-12 16:05:56
Documents
14
Period of Report
2023-01-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d395596d8k.htm   iXBRL 8-K 36119
2 EX-99.1 d395596dex991.htm EX-99.1 12928
6 GRAPHIC g395596g0112075923862.jpg GRAPHIC 4263
  Complete submission text file 0001193125-23-007184.txt   189542

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtyx-20230111.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtyx-20230111_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtyx-20230111_pre.xml EX-101.PRE 11703
8 EXTRACTED XBRL INSTANCE DOCUMENT d395596d8k_htm.xml XML 3471
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 23525998
SIC: 2834 Pharmaceutical Preparations